4//SEC Filing
Nabulsi Azmi 4
Accession 0001209191-23-023989
CIK 0001783183other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:05 PM ET
Size
6.6 KB
Accession
0001209191-23-023989
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Purchase
Common Stock
2023-04-11$8.26/sh+10,000$82,600→ 99,567 total
Holdings
- 2,355.22(indirect: By 401(k))
Common Stock
- 785,700(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.20 to $8.50. The Reporting Person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001791412
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:05 PM ET
- Size
- 6.6 KB